241 related articles for article (PubMed ID: 12074974)
1. Cancer chemopreventive activity of resveratrol.
Bhat KP; Pezzuto JM
Ann N Y Acad Sci; 2002 May; 957():210-29. PubMed ID: 12074974
[TBL] [Abstract][Full Text] [Related]
2. Cancer chemopreventive activity of resveratrol.
Jang M; Pezzuto JM
Drugs Exp Clin Res; 1999; 25(2-3):65-77. PubMed ID: 10370867
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity.
Kundu JK; Shin YK; Kim SH; Surh YJ
Carcinogenesis; 2006 Jul; 27(7):1465-74. PubMed ID: 16474181
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis.
Tsai ML; Lai CS; Chang YH; Chen WJ; Ho CT; Pan MH
Food Funct; 2012 Nov; 3(11):1185-94. PubMed ID: 22842666
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets.
Kundu JK; Shin YK; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1506-15. PubMed ID: 16999939
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol, a natural chemopreventive agent against degenerative diseases.
Ignatowicz E; Baer-Dubowska W
Pol J Pharmacol; 2001; 53(6):557-69. PubMed ID: 11985329
[TBL] [Abstract][Full Text] [Related]
7. Piceatannol inhibits phorbol ester-induced NF-kappa B activation and COX-2 expression in cultured human mammary epithelial cells.
Liu D; Kim DH; Park JM; Na HK; Surh YJ
Nutr Cancer; 2009; 61(6):855-63. PubMed ID: 20155627
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide.
Holian O; Wahid S; Atten MJ; Attar BM
Am J Physiol Gastrointest Liver Physiol; 2002 May; 282(5):G809-16. PubMed ID: 11960777
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.
Subbaramaiah K; Michaluart P; Chung WJ; Tanabe T; Telang N; Dannenberg AJ
Ann N Y Acad Sci; 1999; 889():214-23. PubMed ID: 10668496
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of cancer and cardiovascular disease by resveratrol.
Lin JK; Tsai SH
Proc Natl Sci Counc Repub China B; 1999 Jul; 23(3):99-106. PubMed ID: 10492890
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
Jang M; Cai L; Udeani GO; Slowing KV; Thomas CF; Beecher CW; Fong HH; Farnsworth NR; Kinghorn AD; Mehta RG; Moon RC; Pezzuto JM
Science; 1997 Jan; 275(5297):218-20. PubMed ID: 8985016
[TBL] [Abstract][Full Text] [Related]
12. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Banerjee S; Bueso-Ramos C; Aggarwal BB
Cancer Res; 2002 Sep; 62(17):4945-54. PubMed ID: 12208745
[TBL] [Abstract][Full Text] [Related]
13. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
14. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol and cellular mechanisms of cancer prevention.
Shukla Y; Singh R
Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Resveratrol Derivatives and In Vitro Screening for Potential Cancer Chemopreventive Activities.
Orsini F; Verotta L; Klimo K; Gerhäuser C
Arch Pharm (Weinheim); 2016 Jun; 349(6):414-27. PubMed ID: 27159630
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises.
Signorelli P; Ghidoni R
J Nutr Biochem; 2005 Aug; 16(8):449-66. PubMed ID: 16043028
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells.
Kim YA; Lim SY; Rhee SH; Park KY; Kim CH; Choi BT; Lee SJ; Park YM; Choi YH
Int J Mol Med; 2006 Jun; 17(6):1069-75. PubMed ID: 16685418
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
Cal C; Garban H; Jazirehi A; Yeh C; Mizutani Y; Bonavida B
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):77-93. PubMed ID: 12678904
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
Manna SK; Mukhopadhyay A; Aggarwal BB
J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
